 | • レポートコード：B-MOR-040406 • 出版社/出版日：Mordor Intelligence / 2018年3月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、ファーマコビジランスの世界市場について調べ、ファーマコビジランスの世界規模、市場動向、市場環境、治験段階別（臨床試験前、第I相、第Ⅱ相、第Ⅲ相、第IV相）分析、サービス提供元別（社内、外部委託）分析、タイプ別分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・ファーマコビジランスの世界市場インサイト ・ファーマコビジランスの世界市場環境 ・ファーマコビジランスの世界市場動向 ・ファーマコビジランスの世界市場規模 ・ファーマコビジランスの世界市場規模：治験段階別（臨床試験前、第I相、第Ⅱ相、第Ⅲ相、第IV相） ・ファーマコビジランスの世界市場規模：サービス提供元別（社内、外部委託） ・ファーマコビジランスの世界市場規模：タイプ別 ・ファーマコビジランスの世界市場規模：エンドユーザー別 ・ファーマコビジランスの世界市場：地域別市場規模・分析 ・ファーマコビジランスの北米市場規模・予測 ・ファーマコビジランスのアメリカ市場規模・予測 ・ファーマコビジランスのヨーロッパ市場規模・予測 ・ファーマコビジランスのアジア市場規模・予測 ・ファーマコビジランスの日本市場規模・予測 ・ファーマコビジランスの中国市場規模・予測 ・ファーマコビジランスのインド市場規模・予測 ・ファーマコビジランスの韓国市場規模・予測 ・関連企業情報・競争状況 |
According to WHO, pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The focus of pharmacovigilance is on ADR (adverse drug reactions) and drug toxicity. Increasing number of adverse drug reactions (ADRs) imposes a significant burden on the healthcare system by extending patient morbidity under chronic condition. The global pharmacovigilance market is expected to register a CAGR of 12.8% during the forecast period, 2018 to 2023.
Growing Incidence Rates of ADR and Drug Toxicity
The ADR or adverse drug reaction is defined as an injury caused by taking a medication. Adverse drug reactions (ADR) are far more common than one would think. It is estimated that ADR is one of the leading causes of deaths, right after heart disease, cancer, and stroke, globally. Further, it is estimated that ADRs are the sixth leading cause of death worldwide. With the increase in number of adverse drug reactions (ADRs), there has been a significant burden on the healthcare system. The need to reduce the burden of ADRs has led to an increase in the demand for pharmacovigilance services, thus expanding the global market size.
Other factors driving the market growth are increasing drug consumption and drug development rates and increasing trend of outsourcing pharmacovigilance services.
Lack of Skilled Labor
The process of pharmacovigilance requires the use of skilled professionals to manage adverse events and clinical-trial activities, and contribute to ensure compliance of pharmacovigilance activities. However, the dearth of skilled professionals in the market is restraining its growth,
Additionally, high risk associated with data security is also restraining the market growth.
North America to Dominate the Market
North America dominates the market due to rising mortality rates, adverse drug events, and growing patient concerns for safety and efficacy of drugs.
Major players: ACCENTURE, CLINQUEST GROUP B.V., COGNIZANT, LABORATORY CORPORATION OF AMERICA HOLDINGS, IBM CORPORATION, ARISGLOBAL, ICON PLC, CAPGEMINI, ITCLINICAL, IMEDGLOBAL, FORESIGHT GROUP INTERNATIONAL AG, TAKE SOLUTIONS LTD., PAREXEL INTERNATIONAL CORPORATION, BIOCLINICA WIPRO LTD., UNITED BIOSOURCE CORPORATION amongst others.
Key Developments in the Market
• February 2017: PAREXEL announces definitive agreement to acquire the medical affairs company
• June 2017: Accenture has been named a leader in IDC MarketScape on Life Science Drug Safety Services.
Reasons to Purchase This Report
• Market analysis for the Global Pharmacovigilance Drugs Market, with region-specific assessments and competition analysis on a Global and regional scale.
• Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet (in excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (Droc)
6.1 Market Drivers
6.1.1 Increasing Drug Consumption and Drug Development Rates
6.1.2 Growing Incidence Rates of ADR and Drug Toxicity
6.1.3 Increasing Trend of Outsourcing Pharmacovigilance Services
6.2 Market Restraints
6.2.1 High Risk Associated with Data Security
6.2.2 Lack of Skilled Labor
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Clinical Trial Phase
7.1.1 Preclinical
7.1.2 Phase I
7.1.3 Phase II
7.1.4 Phase III
7.1.5 Phase IV
7.2 By Service Provider
7.2.1 In-house
7.2.2 Contract Outsourcing
7.3 By Type
7.3.1 Spontaneous Reporting
7.3.2 Intensified ADR Reporting
7.3.3 Targeted Spontaneous Reporting
7.3.4 Cohort Event Monitoring
7.3.5 EHR Mining
7.4 By End-User
7.4.1 Hospitals
7.4.2 Research Organizations
7.4.3 Industrial
7.5 By Geography
7.5.1 North America
7.5.1.1 United States
7.5.1.2 Canada
7.5.1.3 Mexico
7.5.2 Europe
7.5.2.1 France
7.5.2.2 United Kingdom
7.5.2.3 Germany
7.5.2.4 Italy
7.5.2.5 Spain
7.5.2.6 Rest of Europe
7.5.3 Asia-Pacific
7.5.3.1 India
7.5.3.2 China
7.5.3.3 Japan
7.5.3.4 Australia
7.5.3.5 South Korea
7.5.3.6 Rest of APAC
7.5.4 Middle East & Africa
7.5.4.1 GCC
7.5.4.2 South Africa
7.5.4.3 Rest of Middle East & Africa
7.5.5 South America
7.5.5.1 Brazil
7.5.5.2 Argentina
7.5.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches
9. Key Players
9.1 Accenture
9.2 Clinquest Group B.V.
9.3 Cognizant
9.4 Laboratory Corporation of America Holdings
9.5 IBM Corporation
9.6 ArisGlobal
9.7 ICON Plc
9.8 Capgemini
9.9 ITClinical
9.10 iMEDGlobal
9.11 Foresight Group International AG
9.12 TAKE Solutions Ltd.
9.13 PAREXEL International Corporation
9.14 BioClinica
9.15 Wipro Ltd.
9.16 United BioSource Corporation
10. Future of the Market